Saved report copy
Recorded
Pharma stocks rise as investors diversify beyond AI-heavy portfolios
The Financial Times reports that pharmaceutical stocks have outpaced the broader market as investors diversify away from concentrated AI exposure, with the S&P 500 Pharmaceutical index gaining 18% in the first eight months versus 13% for the S&P 500. White House pricing agreements, tariff relief, strong clinical-trial results and increased biotech dealmaking have supported the sector. The FT also notes that rising US valuations are prompting investors to consider undervalued European drugmakers.
Reporting used